DCTPP1 and ovarian carcinoma: The screening and use of inhibitors targeting the enzymatic activity of DCTPP1 will enable a more in‐depth exploration of its role in cisplatin resistance in ovarian cancer (OC) and the potential of it serving as a cisplatin treatment enhancer.